{"id":"doi:10.1007/s11883-011-0219-7","kind":"review","title":"Residual Cardiovascular Risk Despite Optimal LDL Cholesterol Reduction with Statins: The Evidence, Etiology, and Therapeutic Challenges","authors":["Uchechukwu K.A. Sampson","Sergio Fazio","MacRae F. Linton"],"author_count":3,"year":2011,"published":"2011-11-18","venue":"Current Atherosclerosis Reports","cited_by":439,"doi":"10.1007/s11883-011-0219-7","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1007/s11883-011-0219-7","archive_url":"https://space-kitty.com/papers/doi:10.1007/s11883-011-0219-7","updated":null,"pmid":"22102062","pmcid":null,"openalex_id":"W2079979713","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["Lipoproteins and Cardiovascular Health"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"cardiovascular-innovation","name":"Cardiovascular Therapeutics","domain_slug":"medicine"}],"cited_in_dossiers":[]}